Jupiter Neurosciences held annual shareholder meeting, with 59% of shares represented

• Jupiter Neurosciences held its annual shareholder meeting on July 22, 2026.
• Shareholders ratified Cherry Bekaert as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Investors adopted an amendment to the 2025 Equity Incentive Plan to add 5.25 million shares for issuance under the plan.
• Shareholders authorized a reverse stock split, with the ratio set within a 1-for-10 to 1-for-100 range at the board’s discretion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034724), on July 27, 2026, and is solely responsible for the information contained therein.